AI can turn complex protocols into first-pass budget inputs, letting sponsors start budgeting sooner while budget builders shift from data entry to review.
|Articles|November 16, 2017
WCG Partners with Veeva on IRB Document Transfer
Advertisement
WIRB-Copernicus (WCG) announced that it is partnering with Veeva Systems to improve the speed and accuracy of institutional review board (IRB) document transfer. WCG will build a seamless connection between WCG’s MyConnexus™ IRB document management web portal and Veeva Vault eTMF. By linking Vault eTMF with MyConnexus, IRB documentation can be automatically uploaded into the customer’s Vault eTMF to provide inspection-ready eTMF documents immediately, and reduce the possibility of human error during IRB document transfer.
Read the full release
Advertisement
Related to this article
Trialbee CEO Matt Walz explores the current impact of AI in delivering practical gains in clinical development and reflects on its future potential, where enrollment predictability may be the biggest prize of all.
In this video interview, Carole Berini, PhD, of Ontada, explains how validated proxies for variables like ECOG performance status can recover not just sample size but the representativeness of hard-to-reach patient populations in real-world oncology studies.
A biomarker test now decides who enters a precision medicine trial, yet results often go unused and assays are not ready when screening opens.
In today's ACT Brief, we examine proportionate analysis frequency in RBQM, how to build trust into real-world evidence foundations for cancer trials, and how rare disease developers monetize regulatory success.
Real-time RBQM requires proportionate analysis frequency matched to data arrival and issue criticality, not continuous reanalysis, because signal churn from over-frequent runs creates alert fatigue and operational noise that obscures meaningful deterioration.
In this video interview, Saamir Pasha and Carole Berini, PhD, of Ontada, explain how building trust into the data foundation—through source lineage, standardization, and reconciliation—is what makes reliable real-world evidence generation in oncology possible.
In today's ACT Brief, we examine how AI surfaces design flaws before enrollment, why site training readiness depends on learning science, and the priorities defining next-generation weight-loss therapies.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AI and Patient Recruitment: Can Predictive Promise Drive True Transformation?
2
Better Site Training Starts With Five Simple Questions
3
Start Study Budgets Sooner With AI-Enabled Protocol Translation
4
How Routine Lab Markers Can Stand In for Missing Functional Status Data
5